TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
ARQT
Arcutis Biotherapeutics
$
()
ARQT
Arcutis presents late-breaking data from INTEGUMENT Phase 3 trials
ARQT
3/19/2023 - 15:33pm
Roivant readout removes 'major overhang' for Arcutis, says Mizuho
ARQT
,
ROIV
3/16/2023 - 09:02am
Arcutis Biotherapeutics reports Q4 EPS ($1.18), consensus ($1.42)
ARQT
3/1/2023 - 07:00am
Arcutis Biotherapeutics submits NDA to U.S. FDA for roflumilast foam 0.3%
ARQT
2/21/2023 - 08:07am
NewAmsterdam appoints John Smither to board of directors
NAMS
,
ARQT
2/6/2023 - 08:13am
Arcutis presents Phase 2 long-term data in adults with chronic plaque psoriasis
ARQT
1/14/2023 - 10:18am
Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
MRK
,
ACRS
,
ARQT
…
12/28/2022 - 08:03am
Arcutis Biotherapeutics submits sNDA application to FDA for ZORYVE
ARQT
12/19/2022 - 08:02am
Arcutis Biotherapeutics says INTEGUMENT-2 trial met primary, secondary endpoints
ARQT
12/12/2022 - 08:30am
Arcutis enrolls first patient in Phase 1b study evaluating ARQ-255
ARQT
12/5/2022 - 08:11am
Arcutis Biotherapeutics announces publication of data on roflumilast cream
ARQT
11/28/2022 - 08:10am
Arcutis Biotherapeutics publishes ESG report
ARQT
11/21/2022 - 09:18am
Arcutis announces ZORYVE cream added to Express Scripts national formularies
ARQT
11/17/2022 - 08:06am
Arcutis Biotherapeutics announces resulst from INTEGUMENT-1 Phase 3 trial
ARQT
11/15/2022 - 08:30am
Arcutis Biotherapeutics reports Q3 EPS ($1.89), consensus ($1.67)
ARQT
11/8/2022 - 16:58pm
dynamic_feed
Breaking News
search
Search
menu
Menu
TheFly.com TheFly.com
